Deadline for application
-PhD in the biomedicine or similar
-Background in vascular biology and PI3K signaling pathway.
-Expertise in epifluorescence and confocal microscopy.
-Experience in working with mice as experimental model system.
-Experience in advanced molecular biology techniques (qPCR, etc).
-A high level of motivation and interest.
-Ability to handle varying workloads and aptitude for teamwork.
-High level of collaborative and communicative skills.
-Good level of English speaking and writing skills (required). Spanish (helpful).
-Experimental design of the project.
-Working with complex genetically engineered mouse models including monitoring of the colony.
-Isolation and culture of primary endothelial cells.
-Isolation of mouse retinas and embryos as main model of study.
-Supervision of master and PhD students.
-Write fellowships applications and manuscripts together with the PI.
-Prepare formal reports for oral and written presentations.
-Data integration and interpretation.
What we offer
-An exciting and innovative research project.
-Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
-Incorporation in a multinational and highly collaborative team.
-The stimulating environment of the Barcelona metropolitan area.
Our research is devoted to study the biology of the endothelium and its role in disease towards the development of therapeutic strategies to target this compartment. Specifically, we aim to untackel the fundamental insigths of vessel growth and function in developmental setting as well as to identify the pathological contexts in which the vasculature plays a critical role either intrinsically, as in vascular anomalies, or extrinsically as in cancer.
Please also visit our unit webpage:
The project receives funding from “la Caixa” Banking Foundation under the Agreement HR18-00120.
Who we are?
Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukaemia and other hematologic malignancies.
The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and development of leukaemia and other malignant haematological pathologies in order to be able to prevent them. We will work for a future in which all leukaemias will be curable.
For further information, please, visit our webpage: http://www.carrerasresearch.org/en and the Josep Carreras non-profit organization: https://www.fcarreras.org/en
The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.
The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.
This EC initiative aims to promote training, professional development, and mobility for all European scientists. The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favors the development of its scientists.
IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, and other legally protected characteristics.
Place of presentation of the candidacies
To apply for this opportunity, please send your resume and a cover letter (incl. the contact details of two referees) to firstname.lastname@example.org in the subject of the message: REF.: PR_MG_09.
Deadline for Applications
Please submit your application by February 22th, 2021.